HDL subfractions distribution in renal transplant recipients: Lack of evidence of a reduction of HDL(2) particles

被引:7
作者
Barbagallo, CA
Averna, MR
Sparacino, V
Cefalu, AB
Caputo, F
Noto, D
Verghi, F
Notarbartolo, A
Barbagallo, CM
机构
[1] UNIV PALERMO,DEPT INTERNAL MED & GERIATR,PALERMO,ITALY
[2] CIV HOSP,DIV NEPHROL,PALERMO,ITALY
[3] UNIV CATANIA,DEPT APPL PHYSIOPATHOL,CATANIA,ITALY
来源
NEPHRON | 1996年 / 72卷 / 03期
关键词
renal transplant recipients; lipoproteins; HDL;
D O I
10.1159/000188904
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Since the high rate of cardiovascular disease in renal transplant recipients, alterations of lipoprotein profile in such patients were extensively evaluated, but the HDL subclass profile was not completely clarified. Renal transplant recipients usually show normal to high plasma levels of HDL cholesterol, even if some investigations suggested a persistence of low HDL(2) levels: this was not useful in terms of cardiovascular protection. We designed this study in order to evaluate HDL subfractions distribution in renal transplant recipients. We studied 55 renal transplant recipients, treated with prednisone, azathioprine and/or cyclosporine, and 34 healthy normolipidemics as controls. In all subjects cholesterol, triglycerides, LDL cholesterol, HDL cholesterol, apolipoproteins A-I and B levels and HDL subfractions, as determined by nondenaturing polyacrylamide gradient gel electrophoresis, were assayed. Renal transplant recipients had cholesterol, triglycerides, LDL cholesterol and apolipoproteins A-I and B levels significantly higher than controls; HDL cholesterol levels were slightly, but not significantly, increased in comparison with controls (respectively 51.1 +/- 15.5 and 46.1 +/- 10.8 mg/dl). Multivariate analysis showed that only the time since transplantation was significantly associated with HDL cholesterol levels. When HDL subfractions were analyzed, renal transplant recipients presented significantly lower levels of HDL(3a) and HDL(3b) and, in males, higher levels of HDL(2b) than controls. HDL cholesterol levels were positively correlated with HDL(2b) levels in both renal transplant recipients and controls, and negatively correlated with HDL(3b) in controls. In conclusion, in renal transplant recipients, we failed to demonstrate any decrease of HDL(2) particles. On the basis of a nonatherogenic HDL profile, we suggest that the increased cardiovascular risk in renal transplant recipients might be accounted for by other risk factors.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 42 条
[1]   LIPOPROTEIN LEVELS AND POSTHEPARIN LIPASE ACTIVITIES IN KIDNEY-TRANSPLANT RECIPIENTS - CYCLOSPORINE VS NON-CYCLOSPORINE-TREATED PATIENTS [J].
ARNADOTTIR, M ;
THYSELL, H ;
NILSSONEHLE, P .
AMERICAN JOURNAL OF NEPHROLOGY, 1991, 11 (05) :391-396
[2]   ELEVATED HIGH-DENSITY-LIPOPROTEIN CONCENTRATIONS IN HEART-TRANSPLANT RECIPIENTS ARE RELATED TO IMPAIRED PLASMA CHOLESTERYL ESTER TRANSFER AND HEPATIC LIPASE ACTIVITY [J].
ATGER, V ;
LECLERC, T ;
CAMBILLAU, M ;
GUILLEMAIN, R ;
MARTI, C ;
MOATTI, N ;
GIRARD, A .
ATHEROSCLEROSIS, 1993, 103 (01) :29-41
[3]   SERUM-LIPID ABNORMALITIES IN HEART-TRANSPLANT RECIPIENTS - PREDOMINANCE OF HDL2-LIKE PARTICLES IN THE HDL PATTERN [J].
ATGER, V ;
CAMBILLAU, M ;
GUILLEMAIN, R ;
FARGE, D ;
DREYFUS, G ;
HAMON, S ;
GIRARD, A ;
CARPENTIER, A ;
MOATTI, N .
ATHEROSCLEROSIS, 1990, 81 (02) :103-110
[4]   SERUM APOLIPOPROTEIN PROFILE OF HYPERTRIGLYCERIDEMIC PATIENTS WITH CHRONIC RENAL-FAILURE ON HEMODIALYSIS - A COMPARISON WITH TYPE-IV HYPERLIPOPROTEINEMIC PATIENTS [J].
AVERNA, MR ;
BARBAGALLO, CM ;
GALIONE, A ;
CARROCCIO, A ;
LABISI, M ;
MARINO, G ;
MONTALTO, G ;
NOTARBARTOLO, A .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (07) :601-602
[5]   FOLLOW-UP OF LIPID AND APOPROTEIN LEVELS IN RENAL-TRANSPLANT RECIPIENTS [J].
AVERNA, MR ;
BARBAGALLO, CM ;
SPARACINO, V ;
CAPUTO, F ;
MANCINO, C ;
CALABRESE, S ;
NOTARBARTOLO, A .
NEPHRON, 1991, 58 (02) :255-256
[6]  
BAGDADE J, 1976, J LAB CLIN MED, V87, P37
[7]   PLASMA HIGH-DENSITY LIPOPROTEIN CONCENTRATIONS IN CHRONIC-HEMODIALYSIS AND RENAL-TRANSPLANT PATIENTS [J].
BAGDADE, JD ;
ALBERS, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (25) :1436-1439
[8]   HYPERTRIGLYCERIDEMIA - A METABOLIC CONSEQUENCE OF CHRONIC RENAL FAILURE [J].
BAGDADE, JD ;
PORTE, D ;
BIERMAN, EL .
NEW ENGLAND JOURNAL OF MEDICINE, 1968, 279 (04) :181-+
[9]   EFFECTS OF CYCLOSPORINE THERAPY ON PLASMA-LIPOPROTEIN LEVELS [J].
BALLANTYNE, CM ;
PODET, EJ ;
PATSCH, WP ;
HARATI, Y ;
APPEL, V ;
GOTTO, AM ;
YOUNG, JB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (01) :53-56
[10]   HIGH-DENSITY AND LOW-DENSITY LIPOPROTEIN SUBFRACTIONS IN SURVIVORS OF MYOCARDIAL-INFARCTION AND IN CONTROL SUBJECTS [J].
BALLANTYNE, FC ;
CLARK, RS ;
SIMPSON, HS ;
BALLANTYNE, D .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1982, 31 (05) :433-437